Company Filing History:
5 out of 37 
1 out of 61 
Years Active: 2021-2024
Title: **Sibylle Dames: Innovator in Nucleic Acid Therapeutics**
Introduction
Sibylle Dames is a prominent inventor based in Berlin, Germany, recognized for her significant contributions to the field of molecular biology and therapeutics. With five patents to her name, she has focused on groundbreaking innovations that address critical health issues, particularly in the realm of cardiovascular diseases and bleeding disorders.
Latest Patents
Among her latest advancements are two notable patents pertaining to nucleic acids designed to inhibit gene expression. The first patent involves nucleic acids aimed at inhibiting the expression of the LPA gene in cells. This invention offers potential treatments for cardiovascular diseases such as coronary heart disease, aortic stenosis, and strokes, by targeting elevated Lp(a)-containing particles. The second patent addresses the inhibition of PROS1 gene expression through nucleic acid products. This innovation holds promise for therapeutic applications in treating bleeding disorders, enhancing treatment options for patients affected by these conditions.
Career Highlights
Sibylle Dames has had a distinguished professional journey, contributing her expertise in various renowned organizations. She has worked with Silence Therapeutics GmbH, a company known for its advancements in RNA-targeted therapeutics. Additionally, she has collaborated with the University of Bern, a notable research institution that supports innovation in biomedical research.
Collaborations
Throughout her career, Sibylle has partnered with various talented individuals in her field. Among her notable collaborators are Christian Frauendorf and Lucas Bethge, both of whom have contributed to her research endeavors and innovation projects, enhancing the impact of her work.
Conclusion
Sibylle Dames stands out as a key figure in the innovation landscape of nucleic acid therapeutics. Her patents not only contribute to scientific advancement but also offer hope for improved treatments in critical areas of health. As her career continues to evolve, the impact of her inventions will likely resonate within the medical community and beyond.